JP2019509318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509318A5 JP2019509318A5 JP2018549896A JP2018549896A JP2019509318A5 JP 2019509318 A5 JP2019509318 A5 JP 2019509318A5 JP 2018549896 A JP2018549896 A JP 2018549896A JP 2018549896 A JP2018549896 A JP 2018549896A JP 2019509318 A5 JP2019509318 A5 JP 2019509318A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- clostridium difficile
- difficile infection
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022076605A JP2022115985A (ja) | 2016-03-24 | 2022-05-06 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
| JP2023183167A JP2024023187A (ja) | 2016-03-24 | 2023-10-25 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662312996P | 2016-03-24 | 2016-03-24 | |
| US62/312,996 | 2016-03-24 | ||
| US201662320053P | 2016-04-08 | 2016-04-08 | |
| US62/320,053 | 2016-04-08 | ||
| PCT/US2017/023958 WO2017165729A1 (en) | 2016-03-24 | 2017-03-24 | Methods for treating and preventing c. difficile infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022076605A Division JP2022115985A (ja) | 2016-03-24 | 2022-05-06 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2019509318A JP2019509318A (ja) | 2019-04-04 |
| JP2019509318A5 true JP2019509318A5 (enExample) | 2020-04-30 |
| JPWO2017165729A5 JPWO2017165729A5 (enExample) | 2024-01-09 |
| JP7458706B2 JP7458706B2 (ja) | 2024-04-01 |
Family
ID=59900751
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549896A Active JP7458706B2 (ja) | 2016-03-24 | 2017-03-24 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
| JP2022076605A Pending JP2022115985A (ja) | 2016-03-24 | 2022-05-06 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
| JP2023183167A Pending JP2024023187A (ja) | 2016-03-24 | 2023-10-25 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022076605A Pending JP2022115985A (ja) | 2016-03-24 | 2022-05-06 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
| JP2023183167A Pending JP2024023187A (ja) | 2016-03-24 | 2023-10-25 | クロストリジウム・ディフィシル感染を処置及び予防するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20170319603A1 (enExample) |
| EP (1) | EP3432891A4 (enExample) |
| JP (3) | JP7458706B2 (enExample) |
| CN (2) | CN119454720A (enExample) |
| AU (3) | AU2017238644B2 (enExample) |
| BR (2) | BR112018069303A2 (enExample) |
| CA (1) | CA3018872A1 (enExample) |
| MX (2) | MX2018011413A (enExample) |
| MY (1) | MY197627A (enExample) |
| PH (1) | PH12018502020A1 (enExample) |
| RU (1) | RU2751509C1 (enExample) |
| SG (2) | SG11201808246SA (enExample) |
| WO (1) | WO2017165729A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201808246SA (en) * | 2016-03-24 | 2018-10-30 | Paratek Pharm Innc | Methods for treating and preventing c. difficile infection |
| TW202206081A (zh) * | 2016-08-03 | 2022-02-16 | 美商派瑞泰Ｓｐｖ２有限公司 | ９—胺甲基米諾四環素化合物及其用途 |
| CN110087655A (zh) * | 2016-11-01 | 2019-08-02 | 帕拉特克药品公司 | 9-氨基甲基米诺环素化合物及其在治疗社区获得性细菌性肺炎(cabp)中的用途 |
| JP7110563B2 (ja) * | 2017-09-06 | 2022-08-02 | 株式会社三洋物産 | 遊技機 |
| JP7110560B2 (ja) * | 2017-09-06 | 2022-08-02 | 株式会社三洋物産 | 遊技機 |
| JP7110562B2 (ja) * | 2017-09-06 | 2022-08-02 | 株式会社三洋物産 | 遊技機 |
| JP2019136429A (ja) * | 2018-02-15 | 2019-08-22 | 株式会社三洋物産 | 遊技機 |
| JP2019136430A (ja) * | 2018-02-15 | 2019-08-22 | 株式会社三洋物産 | 遊技機 |
| JP2019136431A (ja) * | 2018-02-15 | 2019-08-22 | 株式会社三洋物産 | 遊技機 |
| EP3846805A4 (en) * | 2018-09-04 | 2022-08-24 | Paratek Pharmaceuticals, Inc. | Methods of treating mycobacterial infections using tetracycline compounds |
| CN112823014A (zh) * | 2018-10-10 | 2021-05-18 | 营养株式会社 | 艰难梭菌感染的预防和/或治疗剂 |
| AU2021288202A1 (en) * | 2020-06-11 | 2022-12-08 | Paratek Pharmaceuticals Inc. | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof |
| PT117254B (pt) | 2021-05-26 | 2024-04-18 | Hovione Farm S A | Método de síntese de compostos 9-aminometil tetraciclinas |
| JP2023105292A (ja) * | 2022-07-21 | 2023-07-28 | 株式会社三洋物産 | 遊技機 |
| JP2023105293A (ja) * | 2022-07-21 | 2023-07-28 | 株式会社三洋物産 | 遊技機 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2113614A1 (en) * | 1991-07-24 | 1993-02-04 | Scott Donald Whalen | Antimicrobial treatment methods and compositions |
| MXPA03000055A (es) * | 2000-07-07 | 2003-07-14 | Tufts College | Compuestos de monociclina sustituidos en posicion 9.. |
| US7553828B2 (en) * | 2001-03-13 | 2009-06-30 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
| EP2332546A1 (en) * | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of stroke |
| JP2009521456A (ja) * | 2005-12-22 | 2009-06-04 | ワイス | チゲサイクリンでの胃腸管感染症の治療法 |
| EP1991236A2 (en) * | 2006-01-24 | 2008-11-19 | Paratek Pharmaceuticals, Inc. | Methods of increasing oral bioavailability of tetracyclines |
| TW202021946A (zh) * | 2008-05-19 | 2020-06-16 | 美商派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| AU2010213773B2 (en) * | 2009-02-11 | 2014-07-17 | Cedars-Sinai Medical Center | Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome |
| JP5965389B2 (ja) * | 2010-04-15 | 2016-08-03 | プロゲニクス ファーマシューティカルズ インコーポレーテッドＰｒｏｇｅｎｉｃｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | クロストリジウム・ディフィシル関連感染症および疾患を治療するための抗体 |
| WO2012050826A1 (en) * | 2010-09-29 | 2012-04-19 | St. Jude Children's Research Hostpital | Methods for treating clostridium difficile infections |
| WO2012065028A2 (en) * | 2010-11-11 | 2012-05-18 | Concert Pharmaceuticals Inc. | Substituted tetracyclines |
| KR102222273B1 (ko) * | 2013-02-04 | 2021-03-08 | 세레스 테라퓨틱스, 인코포레이티드 | 조성물 및 방법 |
| US20140274800A1 (en) * | 2013-03-13 | 2014-09-18 | Procarta Biosystems Ltd. | Transcription factor decoys for the treatment and prevention of infections caused by bacteria including clostridium difficile |
| SG11201808246SA (en) * | 2016-03-24 | 2018-10-30 | Paratek Pharm Innc | Methods for treating and preventing c. difficile infection |
-
2017
- 2017-03-24 SG SG11201808246SA patent/SG11201808246SA/en unknown
- 2017-03-24 CN CN202411540120.0A patent/CN119454720A/zh active Pending
- 2017-03-24 CN CN201780032098.0A patent/CN109152789A/zh active Pending
- 2017-03-24 BR BR112018069303A patent/BR112018069303A2/pt not_active Application Discontinuation
- 2017-03-24 SG SG10201913559VA patent/SG10201913559VA/en unknown
- 2017-03-24 WO PCT/US2017/023958 patent/WO2017165729A1/en not_active Ceased
- 2017-03-24 AU AU2017238644A patent/AU2017238644B2/en active Active
- 2017-03-24 MY MYPI2018001628A patent/MY197627A/en unknown
- 2017-03-24 EP EP17771214.8A patent/EP3432891A4/en active Pending
- 2017-03-24 MX MX2018011413A patent/MX2018011413A/es unknown
- 2017-03-24 CA CA3018872A patent/CA3018872A1/en active Pending
- 2017-03-24 RU RU2018134899A patent/RU2751509C1/ru active
- 2017-03-24 JP JP2018549896A patent/JP7458706B2/ja active Active
- 2017-03-24 BR BR122024000249-3A patent/BR122024000249A2/pt not_active Application Discontinuation
- 2017-03-24 US US15/468,354 patent/US20170319603A1/en not_active Abandoned
-
2018
- 2018-09-20 MX MX2023004969A patent/MX2023004969A/es unknown
- 2018-09-21 PH PH12018502020A patent/PH12018502020A1/en unknown
-
2019
- 2019-12-06 US US16/705,379 patent/US20200281948A1/en not_active Abandoned
-
2022
- 2022-05-06 JP JP2022076605A patent/JP2022115985A/ja active Pending
-
2023
- 2023-02-14 AU AU2023200798A patent/AU2023200798A1/en not_active Abandoned
- 2023-10-25 JP JP2023183167A patent/JP2024023187A/ja active Pending
-
2024
- 2024-01-29 US US18/425,171 patent/US20250049819A1/en active Pending
-
2025
- 2025-03-20 AU AU2025202020A patent/AU2025202020A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509318A5 (enExample) | ||
| Goderska et al. | Helicobacter pylori treatment: antibiotics or probiotics | |
| Livermore | Introduction: the challenge of multiresistance | |
| Meini et al. | Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature | |
| Chou et al. | Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit | |
| HOFFMANN et al. | Use of Peroperative CefoxitinR to Prevent Infection After Colonic and Rectal Surgery | |
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| RU2018140463A (ru) | 9-аминометилминоциклиновые соединения и способы их применения для лечения инфекций мочевых путей (имп) | |
| Wang et al. | Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates | |
| Brook et al. | Management of postirradiation infection: lessons learned from animal models | |
| JP2025041746A5 (enExample) | ||
| Malangoni | Necrotizing soft tissue infections: are we making any progress? | |
| Cunha et al. | Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection | |
| Ogata et al. | Thoracic empyema caused by Campylobacter rectus | |
| Matsuda et al. | A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia | |
| Huband et al. | Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023) | |
| Argentino et al. | Prevention of recurrence of enteric peritonitis in peritoneal dialysis with Escherichia coli Nissle 1917: a case-series study | |
| Rahamat-Langendoen et al. | Disseminated Rhodococcus equi infection in a kidney transplant patient without initial pulmonary involvement | |
| Vandenhende et al. | Successful daptomycin lock therapy for implantable intra-arterial catheter infection in a patient with liver metastases of colon cancer | |
| Hiyama et al. | Significance of anaerobic bacteria in postoperative infection after radical cystectomy and urinary diversion or reconstruction | |
| Larnè et al. | Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy | |
| Saha et al. | Antimicrobials in growth and development | |
| Savvidou et al. | Primary pyomyositis and disseminated septic pulmonary emboli: a reactivated staphylococcal infection? | |
| Badejo et al. | Bacteriology and clinical course of camel-bite wound infections | |
| Khamdamov et al. | Assessment of the effectiveness of diagnosis and therapy of patients with chronic bacterial prostatitis |